Propanc Biopharma, Inc.
PPCB
Revenue
0.00
0.000.00%
-Assets
72.37k
▲35.03k▲93.82%
3 Months ChangeLiabilities
3.85M
▲114.57k▲3.07%
3 Months ChangeFree Cash Flow
99.81k
▲99.81k∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-27
Form 8-K
ID: 0001493152-24-038462
2024-08-30
Form 8-K
ID: 0001493152-24-034647
2024-08-15
Form 8-K
ID: 0001493152-24-032469
2024-08-07
Form 8-K
ID: 0001493152-24-030540
2024-07-02
Form 8-K
ID: 0001493152-24-025929
2024-06-21
Form 8-K
ID: 0001493152-24-024632
2024-06-12
Form 8-K
ID: 0001493152-24-023525
2024-06-05
Form 8-K
ID: 0001493152-24-022624
2024-05-16
Form 8-K
ID: 0001493152-24-020101
2024-05-15
Form 10-Q
ID: 0001493152-24-019940